Preventive Medicine: The Need of the Hour
Keywords:
NAAbstract
It gives me great pleasure, to write this editorial for the International Journal of Preventive Cardiology. To create awareness, develop, awareness, educational, and preventive strategies, a professional society, SASAT was established at the University of Minnesota in 1993. Many international conferences have been organized worldwide and several books have been published on this topic of great public health interest.1-5 Despite the best efforts of the professional societies, global health organizations, published guidelines and scientific statements, the cardiometabolic diseases have increased in their prevalence and incidence, to epidemic proportions worldwide.6-9 Nearly half of all the adults in the United States, have some type of cardiovascular disease or the other (CVD), defined as coronary artery disease, heart failure, stroke or high blood pressure, according to the American Heart Association (AHA)’s annual report, “Heart and Stroke Statistics-2019.”10 AHA data shows, that more than 121 million adults had cardiovascular disease in 2016, a number which is slowly on the rise. Seminal studies of Framingham Heart Group described the risk factors for the development of heart diseases half a century ago, yet vascular diseases are the number one killer worldwide and have retained this status for over a century. An estimated 18 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
How to cite this article:
Rao GHR. Preventive Medicine: The Need of the Hour. Int J Preven Cardio 2021; 1(1): 1-3.
References
Rao GHR: (Editor): Handbook of Platelet Physiology and Pharmacology, Kluwer Academic Publishers, Boston, 1999. ISBN # 0-7923-8538-1
Rao GHR: (Editor): Coronary Artery Disease in South Asians: Epidemiology, Risk Factors, Prevention. Jaypee Medical Publishers, New Delhi, India, 2001, ISBN #81-7179-811-X.
Rao GHR: (Editor): Coronary Artery Disease: Risk Factors, Pathophysiology and Prevention. Jaypee Medical Publishers, New Delhi, India. 2005, ISBN # 81-8061-450-6.
Rao GHR: (Editor): Handbook on Coronary Artery Disease, McMillan Medical Communications (Springer Healthcare), New Delhi, India. 2016.
Rao GHR: Manual of Blood Platelet Physiology and Pharmacology, JP Medical Publishers, New Delhi, India. 2018.
Rao GHR: Prevention or reversal of Cardiometabolic Diseases. J. Clin & Preventive Cardiology. 7 (1); 22-28, 2018.
Rao GHR: Predictive and Preventive Healthcare: Integration of Emerging Technologies. Point of View. J. Clin Res in Diab. & Endocrinol. 1(1): 1-8, 2018.
Rao GHR: Cardiometabolic Dieses: A global perspective. J of Cardiol Cardiovasc. Ther. 12 (2): JOCCT. MSID. 55834 (2018).
Rao GHR: Global Syndemic of Metabolic Diseases. Editorial. J. Diab & Clin Res. 1(1):2-4, 2018.
Benjamin EJ, Muntner P, Alonso S et al: Heart Disease and Stroke Statsitics-2019 Update: A Report of the American Heart Association Circ. 2019;139: e56-e528.
Di Cesare M, Bennett JE, Best N et al: The contributions of risk trends to cardiometabolic mortality decline in 26 industrialized countries. Int J Epid. 42 (3): 838-48, 2013.
Bernd Sebastian Kamps Christian Hoffman: COVID-REFERENCE: https://covidreference.com
Tian H, Liu Y et al: An investigation of transmission control measures for the first 50 days of the COBID-19 epidemic in China Science 2020. https://doi.org/10.1126/scince.abb6105
Yusuf S, Hawken S, Ounpuu S et al: Effect of potentially modifiable risk factors associated with myocardial infraction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (9438):937-52, 2004.
Khera AV, Emdin CA, Drake I et al: Genetic risk, adherence to a healthy lifestyle, and coronary artery disease. N Engl. J. Med. 375:2349-2358, 2016.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 International Journal of Preventive Cardiology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
